I think it's important, when you're making policy such as this, to really understand that this is an issue for the Canadian government, not an issue for the generic industry. If in fact we want to make these products available in an affordable manner to these countries in order to save lives, we have to come up with a policy that the generic industry can take advantage of.
And it has to be simple, or I will not, and neither will any of the other generic companies operating in Canada, use our resources to make available products on which we're not going to make any money. We'll do it because it's the right thing to do as a Canadian company, but you have to make the policy such that it works easily.